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Abstract
Study design: Retrospective comparative study.
Objective: Whereas smoking has been shown to affect the fusion rates for patients undergoing an anterior cervical discectomy
and fusion (ACDF), the relationship between smoking and health-related quality of life outcome measurements after an ACDF is
less clear. The purpose of this study was to evaluate whether smoking negatively affects patient outcomes after an ACDF for
cervical degenerative pathology.
Methods: Patients with tumor, trauma, infection, and previous cervical spine surgery and those with less than a year of follow-up
were excluded. Smoking status was assessed by self-reported smoking history. Patient outcomes, including Neck Disability Index,
Short Form 12 Mental Component Score, Short Form 12 Physical Component Score (PCS-12), Visual Analogue Scale (VAS) arm
pain, VAS neck pain, and pseudarthrosis rates were evaluated. Outcomes were compared between smoking groups using multiple
linear and logistic regression, controlling for age, sex, and body mass index (BMI), among other factors. A P value <.05 was
considered significant.
Results: A total of 264 patients were included, with a mean follow-up of 19.8 months, age of 53.1 years, and BMI of 29.6 kg/m2.
There were 43 current, 69 former, and 152 nonsmokers in the cohort. At baseline, nonsmokers had higher PCS-12 scores than
current smokers (P ¼ .010), lower VAS neck pain than current (P ¼ .035) and former (P ¼ .014) smokers, as well as lower VAS
arm pain than former smokers (P ¼ .006). Postoperatively, nonsmokers had higher PCS-12 scores than both current (P ¼ .030)
and former smokers (P ¼ .035). Smoking status was not a significant predictor of change in patient outcome in multivariate
analysis.
Conclusions: Whereas nonsmokers had higher function and lower pain than former or current smokers preoperatively,
smoking status overall was not found to be an independent predictor of outcome scores after ACDF. This supports the notion
that smoking status alone should not deter patients from undergoing ACDF for cervical degenerative pathology.
Keywords
anterior cervical discectomy and fusion, arm pain, neck disability index, neck pain, patient reported outcome measurements,
Short Form-12 health survey, smoking, Visual Analogue Score
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Introduction
Anterior cervical discectomy and fusion (ACDF) remains a
mainstay in the treatment of degenerative disorders of the cervical spine, decompressing traversing nerve roots and restoring
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anatomical lordosis.1 It has been well established in the literature that smoking has a negative impact on fusion rate, rate of
adjacent segment disease, amount of dysphagia, and wound
healing postoperatively.2-4 Given its major impact on microvascular circulation and pulmonary function, smoking cessation becomes a very important modifiable risk factor for
improving the success rate following ACDF.
Whereas the increased risk of morbidity has been clearly
established, the relationship of smoking and health-related
quality of life (HRQOL) outcome measurements remains
poorly delineated in patients undergoing ACDF. Epidemiological studies have demonstrated an overall decrease or loss of
HRQOL years in smokers compared with nonsmokers.5 The
association of smoking and decrease in HRQOL has been
defined in the lumbar spine but has not been clearly established
in the cervical spine.6-8 Jansson et al6 demonstrated that in
patients undergoing a lumbar decompression for disc herniation, less improvement in HRQOL was seen in smokers compared with nonsmokers.
A successful patient selection algorithm for ACDF requires
the identification of modifiable risk factors and their optimization preoperatively. Preoperative smoking cessation for patients
undergoing ACDF leads to decreased pseudarthrosis, postoperative dysphagia, and wound complications. However, the relationship of smoking status, especially overall smoking history,
and change in HRQOL after ACDF is poorly understood. The
purpose of this study was to identify changes in HRQOL measures over time—or “treatment effect”—between active smokers, former smokers, and nonsmokers undergoing ACDF.

Methods
After institutional review board approval was obtained, a retrospective review of medical records was performed. The data
was collected from fellowship-trained orthopaedic spine surgeons from January 1, 2015, until December 31, 2016, with all
procedures performed at a single institution. Patients older than
18 years and with a diagnosis of cervical myelopathy, radiculopathy, or radiculomyelopathy who underwent an elective 1-5
level ACDF were included. Patients were sorted into 3 groups
based on their self-reported smoking status: nonsmoker, former
smoker, and current smoker. Patients younger than 18 years
and those undergoing surgery for trauma, infection, metastatic
disease, and revision surgery and those with less than 1 year of
follow-up were excluded from the study.
Patient-reported scores, including the Neck Disability Index
(NDI), Short Form 12 Physical Component Score (PCS-12),
Short Form 12 Mental Component Score (MCS-12), and Visual
Analogue Scale Neck (VAS Neck) and Arm (VAS Arm) pain
scores were prospectively maintained and collected preoperatively and postoperatively up to the 1-year time point. Demographic data, including age, body mass index (BMI), smoking
status, and gender was also recorded.
Analysis comparing pseudarthrosis rates between smoking
groups was then conducted based on physician-reported diagnosis of clinical pseudarthrosis and measurements performed
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on imaging from the institution’s Picture Archiving and Communication System (PACS, Siemens Magic Software, Munich
Germany; precision of 0.1 mm). Because routine CT scans are
not typically obtained postoperatively, the authors of this study
used flexion and extension X-rays in PACS, excluding images
taken before 6 months postoperatively. Criteria for radiographic pseudarthrosis were based on those described previously by Song et al,9 where a superjacent segment motion
4 mm and interspinous distance 1 between any of the fused
vertebrae indicates presence of pseudarthrosis.9 The groups
were also compared for differences in revision surgery rates.
Standard descriptive statistics, including mean and 95% CI,
were used to analyze patient demographic data and outcomes
for the entire cohort. Baseline differences between groups were
compared using 1-way ANOVA and Bonferroni post hoc analysis. Recovery ratios (RRs) were calculated to compare
improvements in each outcome between groups. The RR was
calculated as follows: (Postoperative score  Preoperative
score)/(Optimal score  Baseline score). Optimal scores for
PCS-12 and MCS-12 were defined as 100, whereas those for
NDI, VAS Neck pain, and VAS Arm pain were 0.10 The change
in outcomes after surgery, pseudarthrosis parameters, and revision surgery between groups were compared using either linear
or logistic regression analysis controlling for age, sex, BMI,
months followed up, preoperative symptom duration, number
of levels fused, graft type, preoperative diagnosis, American
Society of Anesthesiologist physical status classification system, and Charlson Comorbidity Index. Pearson w2 analysis was
used to determine any difference in revision surgery or pseudarthrosis rates with respect to smoking status. Binary logistic
regression, controlling for age, sex, BMI, and so on, was used
to determine whether smoking status was an independent predictor of revision surgery or pseudarthrosis. A P value <.05 was
considered to be statistically significant. A power analysis for
each preoperative and postoperative outcome was performed to
determine whether the study was powered sufficiently to detect
a difference equal to or greater than the appropriate minimum
clinically important difference (MCID) between groups at a
significance level of a < .05 using the variance measured in
our sample.11 The following MCID values were used: NDI, 15
points; PCS-12, 8.1; MCS-12, 4.7; VAS Neck pain, 2.6; and
VAS Arm pain, 4.1.12,13

Results
A total of 264 patients were included in the study: 43 (16.3%)
patients were identified as current smokers, 69 (26.1%) were
former smokers, and 152 (57.6%) were nonsmokers in the
cohort. There were 123 (46.6%) male and 141 (53.4%) female
patients in the cohorts. The average follow-up for outcome
scores was 19.8 [19.0, 20.6] months. The mean follow-up for
radiographic measurements was 12.0 [1.4, 22.7] months. The
mean age was 53 [52, 54] years, and the mean BMI was
29.6 kg/m2 [28.8, 30.3]. There were a total of 61 one-level
fusions (23%), 125 two-level fusions (47%), 65 three-level
fusions (25%), 12 four-level fusions (5%), and 1 five-level

52

Global Spine Journal 11(1)

Table 1. Descriptive Statistics of Cohort by Smoking Status (n ¼ 264).
Overall
(n ¼ 264)
Age, mean [95% CI]
Sex
M, n (%)
F, n (%)
BMI, kg/m2, mean [95% CI]
Months follow-up, mean [95% CI]
Symptom duration, n (%)
<1 Month
1-3 Months
3-6 Months
6 Months to 2 years
2 Yearsþ
Number of levels fused, n (%)
1
2
3
4
5
Graft type, n (%)
Allograft
Iliac crest bone graft
Diagnosis, n (%)
Radiculopathy
Myelopathy
Myeloradiculopathy
ASA, n (%)
1
2
3
4/5
CCI, n (%)
0
1
2
3
4þ

53 [52, 54]
123 (47%)
141 (53%)
29.6 [28.8, 30.3]
19.8 [19.0, 20.6]
18 (6.8%)
41 (15.5%)
46 (17.4%)
72 (27.3%)
87 (33.0%)

Never Smoker
(n ¼ 152)
52 [51, 54]
71 (47%)
81 (53%)
29.2 [28.3, 30.1]
19.9 [18.8, 21.0]

Current Smoker
(n ¼ 43)
52 [49, 54]
21 (49%)
22 (51%)
29.6 [27.7, 31.6]
18.5 [16.9, 20.1]

Former Smoker
(n ¼ 69)
56 [53, 58]
31 (45%)
38 (55%)
30.3 [28.8, 31.8]
20.3 [18.9, 21.7]

11 (7.2%)
23 (15.1%)
28 (18.4%)
41 (27.0%)
49 (31.3%)

2
5
4
13
19

(4.7%)
(11.6%)
(9.3%)
(30.2%)
(45.2%)

5 (7.2%)
13 (18.8%)
14 (20.3%)
18 (26.1%)
19 (27.6%)

35 (23%)
64 (42%)
45 (30%)
7 (5%)
1 (<1%)

14
20
7
2
0

(33%)
(47%)
(16%)
(4%)
(0%)

12 (17%)
41 (59%)
13 (19%)
3 (4%)
0 (0%)

P Valuea
.089
.921

.487
.265
.784

.259
61 (23%)
125 (47%)
65 (25%)
12 (5%)
1 (<1%)

.682
243 (92.0%)
21 (8.0%)

139 (91.4%)
13 (8.6%)

122 (46.2%)
64 (24.2%)
78 (29.6%)
n ¼ 196
12 (6.1%)
135 (68.9%)
49 (25%)
0 (0%)
n ¼ 199
27 (13.6%)
39 (19.6%)
60 (30.2%)
50 (25.1%)
23 (11.5%)

65 (42.8%)
38 (31.1%)
49 (26.1%)
n ¼ 12
10 (83.3%)
2 (16.7%)
0 (0%)
0 (0%)
n ¼ 122
20 (16.4%)
25 (20.5%)
42 (34.4%)
23 (18.9%)
12 (9.8%)

41 (95.3%)
2 (4.7%)

63 (91.3%)
6 (8.7%)

23
11
9
n
83
15
37
0
n
4
7
6
7
5

34 (49.3%)
15 (21.7%)
20 (29.0%)
n ¼ 49
28 (57.1%)
11 (22.4%)
10 (20.5%)
0 (0%)
n ¼ 48
3 (6.3%)
7 (14.6%)
12 (25.0%)
20 (41.6%)
6 (12.5%)

.604
(53.5%)
(25.6%)
(20.9%)
¼ 135
(61.5%)
(11.1%)
(27.4%)
(0%)
¼ 29
(13.8%)
(24.1%)
(20.7%)
(24.1%)
(17.3%)

.086

.092

Abbreviations: M, male; F, female; BMI, body mass index; ASA, American Society of Anesthesiologist physical status classification system; CCI, Charleston
Comorbidity Index.
a
Baseline demographics were compared between groups with independent samples t-test, Pearson chi-square analysis, or Fisher’s Exact test.

fusion (<1%). Baseline demographic data for patients in the
cohort are given in Table 1.

HRQOL Outcome Measurements
At baseline, PCS-12 was significantly higher in the nonsmoker
group than in the current smoker group, with a significant mean
difference of 4.2 points ([0.8, 7.7], P ¼ .010) between the
groups. Additionally, VAS neck scores were significantly
lower preoperatively for nonsmokers than both current and
former smokers, with mean differences of 1.2 ([2.5,
0.1], P ¼ .035) and 1.0 ([2.2, 0.2], P ¼ .014) points,
respectively. VAS arm pain scores were only significantly different between never and former smokers by a mean difference
of 1.3 ([2.5, 0.3], P ¼ .006) points. Neither MCS-12 nor
NDI were found to significantly differ between smoking groups

at baseline (Table 2). Postoperatively, only PCS-12 was found
to be significantly higher in nonsmokers than both current
smokers and former smokers, with mean differences of 5.1
([0.4, 9.8], P ¼ .030) and 4.1 ([0.2, 8.0], P ¼ .035) points,
respectively. None of the other outcome scores significantly
differed between the smoking groups at postoperative measurements (Table 2).
On multiple linear regression analysis, smoking status was
found to not be a significant predictor of HRQOL changes after
surgery for any of the outcome measures (Table 2). Other
variables that came to significance included the following:
greater follow-up (months) for NDI (b ¼ 0.468 [0.078,
0.857]; P ¼ .019), VAS Neck pain (b ¼ 0.084 [0.028,
0.139]; P ¼ .003), and VAS Arm pain (b ¼ 0.074 [0.016,
0.132]; P ¼ .012) and use of iliac crest bone graft for VAS
arm pain (b ¼ 1.529 [0.111, 2.948]; P ¼ .035). When assessing
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Table 2. Health-Related Quality-of-Life Outcome Measurement Comparisons Between Smoking Groups.

PCS-12

MCS-12

NDI

VAS Neck

VAS Arm

Pre
Post
RR
Pre
Post
RR
Pre
Post
RR
Pre
Post
RR
Pre
Post
RR

Never Smoker
(n ¼ 152)

Current Smoker
(n ¼ 43)

34.6 [33.2, 35.9]
42.4 [40.6, 44.1]
0.11 [0.09, 0.13]
45.7 [43.8, 47.8]
50.2 [48.4, 52.0]
0.04 [0.0, 0.08]
40.1 [36.8, 43.3]
23.4 [19.7, 26.8]
0.37 [0.27, 0.47]
5.2 [4.7, 5.7]
3.0 [2.6, 3.5]
0.41 [0.31, 0.52]
4.7 [4.1, 5.2]
2.6 [2.1, 3.1]
0.51 [0.37, 0.64]

30.4 [28.0, 32.5]
37.3 [34.4, 41.1]
0.09 [0.05, 0.13]
44.1 [40.3, 47.8]
49.2 [45.7, 52.7]
0.04 [0.04, 0.13]
46.5 [41.4, 51.5]
30.0 [22.7, 36.4]
0.34 [0.18, 0.49]
6.4 [5.6, 7.2]
3.6 [2.7, 4.6]
0.40 [0.26, 0.54]
5.6 [4.7, 6.6]
2.7 [1.9, 3.5]
0.51 [0.37, 0.65]

Former Smoker
(n ¼ 69)
32.0
38.3
0.09
45.0
46.7
0.01
45.2
28.4
0.38
6.2
3.2
0.46
6.0
3.2
0.48

[30.3, 33.8]
[35.7, 41.0]
[0.05, 0.12]
[42.4, 47.7]
[43.8, 49.6]
[0.05, 0.06]
[40.7, 50.0]
[23.0, 33.7]
[0.28, 0.48]
[5.5, 6.8]
[2.4, 3.8]
[0.30, 0.62]
[5.3, 6.6]
[2.5, 3.9]
[0.37, 0.60]

One-Way ANOVA,
P Value

Multiple Linear
Regression, P Value

0.004a
0.006a
0.455
0.720
0.137
0.573
0.035b
0.105
0.919
0.003a
0.349
0.860
0.006a
0.290
0.966

0.357
—
0.160
—
0.324
—
0.832
—
0.489
—

Abbreviations: PCS-12, Short Form 12 Physical Component Score; MCS-12, Short Form 12 Mental Component Score; NDI, Neck Disability Index; VAS, Visual
Analogue Scale; RR, recovery ratio.
a
Indicates statistical significance.
b
Bonferroni post hoc analysis revealed no significant differences between smoking groups.

Table 3. Pseudarthrosis/Revision Surgery Rates and Smoking Status Among Smoking Groups.
Overall
(n ¼ 264)
Clinical diagnosis of pseudarthrosis?
Yes, n (%)
No, n (%)
Radiographic criteria of pseudarthrosis?
Yes, n (%)
No, n (%)
Revision surgery?
Yes, n (%)
No, n (%)

Never Smoker
(n ¼ 152)

23 (8.7%)
241 (91.3%)
(n ¼ 150)
21 (14.0%)
129 (86.0%)

12
140
(n
14
73

(7.9%)
(92.1%)
¼ 87)
(16.1%)
(83.9%)

22 (8.3%)
242 (91.7%)

15 (9.9%)
137 (90.1%)

RR for each outcome, all groups noted similar amounts of
improvement from baseline (Table 2).

Pseudarthrosis/Revision Surgery and Smoking Status
There were a total of 23 patients (8.71%) with a clinical diagnosis of pseudarthrosis. Of these, 12 were in the nonsmoker
group (52.2%), 2 were in the current smoker group (8.7%), and
9 were in the former smoker group (39.1%); however, these
differences were not statistically significant (P ¼ .266). Based
on the criteria used by Song et al,9 21 of 150 patients (14.0%)
had radiographic evidence of pseudarthrosis. There were 14
patients in the nonsmoking group (16.1%), 1 patient in the
current smoking group (3.8%), and 6 patients in the former
smoking group (16.2%), with no significant differences
between groups (P ¼ .260). Using binary logistic regression,
smoking status was not a significant predictor of clinical
pseudarthrosis (P ¼ .152) or radiographic pseudarthrosis

Current
Smoker
(n ¼ 43)
2
41
(n
1
25

(4.7%)
(95.3%)
¼ 26)
(3.8%)
(96.2%)

3 (7.0%)
40 (93.0%)

Pearson w2 or
Fisher Exact
Test, P Value

Binary Logistic
Regression,
P Value

(13.0%)
(87.0%)
¼ 37)
(16.2%)
(83.8%)

.266

.152

.260

.802

4 (5.8%)
65 (94.2%)

.562

.196

Former Smoker
(n ¼ 69)
9
60
(n
6
31

(P ¼ .802). There was no significant difference between groups
with regard to revision rates (P ¼ .562), with 15 nonsmokers
(9.9%), 3 current smokers (7.0%), and 4 former smokers
(5.8%) undergoing revision surgery. Binary logistic regression
did not identify smoking status as a significant predictor of
revision surgery (P ¼ .196; Table 3). Based on results of the
post hoc power analysis, preoperative and postoperative outcome comparisons were sufficiently powered (Power ¼ 0.99).

Discussion
In this study, the major aim was to determine the effect of
smoking status on the HRQOL outcomes after an ACDF.
Despite the well-known increase in general morbidity following ACDF and its relationship to fusion status, the effect of
smoking on HRQOL outcome measurements is not as well
studied.11-15 HRQOL outcomes may be used as a proxy for
overall well-being for patients receiving various types of spine
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surgery, including ACDF.14-16 Both surgeons and patients must
be cognizant of the potential associated risks of smoking prior
to performing ACDF.
In the current study, nonsmokers exhibited higher baseline
PCS-12 scores than the current smoker group, with a mean
difference of 4.3 points ([0.8, 7.7], P ¼ .010). This group was
also found to have higher postoperative PCS-12 scores than
both the current and former smoking groups, with mean differences of 5.1 ([0.4, 9.8], P ¼ .030) and 4.1 ([0.2, 8.0], P ¼ .035)
points, respectively. The nonsmoking group also had lower
baseline VAS neck pain scores than both the current and former
smoking group, with mean differences of 1.3 ([2.5, 0.1],
P ¼ .035) and 1.2 ([2.2, 0.2], P ¼ .014), respectively, and
lower baseline VAS arm pain scores than the former smoking
group by a mean difference of 1.4 ([2.5, 0.3], P ¼ .006)
points. VAS neck and arm pain scores were not significantly
different between groups at postoperative measurements. Additionally, neither NDI nor MCS-12 scores were significantly
different between groups at baseline or during postoperative
measurements. Finally, both linear regression and RR analyses
indicated no significant change in treatment effect between
groups for any of the outcome measures examined.
Whereas nonsmokers reported less disability at baseline in
terms of PCS-12 and VAS arm and neck scores, they had
similar pain scores and a similar improvement in RR as the
other groups postoperatively. In addition, smoking status was
not found to be a significant predictor of change in treatment
effect for any of the included outcome measures. These results
suggest that all patients may benefit to a similar degree when
undergoing ACDF, regardless of smoking status. However, it is
not clear to what degree smoking cessation will actually
improve baseline scores in those who smoke. Moreover, the
fact that the current study found no significant differences in
treatment effect over time between smoking groups suggests
that insurance companies need not deny coverage to smokers
who require ACDF to address degenerative cervical symptoms,
especially those who do not quit using tobacco 6 weeks prior to
surgery.17
Current literature regarding smoking status on cervical surgery show conflicting evidence. Davis et al18 conducted a prospective study comparing nonunion rates in patients
undergoing ACDF and cervical disc replacement. They identified that at 48 months of follow-up, nonsmokers had a greater
improvement in NDI, VAS for neck pain, SF-12 MCS, and SF12 PCS compared with smokers.18 In a study evaluating multiple surgical techniques for patients with cervical myelopathy,
Tetreault et al19 reported that nonsmokers were more likely to
experience improvement in the modified Japanese Orthopedic
Association score outcomes than smokers at the 1-year postoperative mark. Similarly, although they did not use HRQOL
outcome metrics, Eubanks et al20 and Hilibrand et al2 reported
worse outcomes after cervical spine surgery in smokers
than nonsmokers.3 These findings are different from this
study’s findings and suggest that more studies are needed to
determine the relationship between smoking and patient
outcomes for ACDF.
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Although this current study was not designed to look at
pseudarthrosis rates, clinical and radiographic data was used
to analyze the cohort. Radiographic measurements described
by Song et al9 were used to determine the presence of a radiographic pseudarthrosis, with an overall rate of 14.0% in the
cohort with no significant difference between groups (P ¼
.260). Binary logistic regression found that smoking status was
not a significant predictor of clinical (P ¼ .152) or radiographic
(P ¼ .802) pseudarthrosis. This is consistent with current literature analyzing pseudarthrosis after ACDF that shows conflicting evidence.2,7,8,16,20-25 In a prospective study, An et al21
compared the use of allograft-demineralized bone matrix composite versus autograft for treatment of 77 patients undergoing
ACDF and found no significant difference in the fusion rate of
smokers (52.9%) and nonsmokers (72.1%; P ¼ .13).21 Two
other retrospective studies by Lau et al 23 and Luszczyk
et al24 found no significant differences in nonunion rates
between nonsmokers and smokers (P ¼ .163 and P ¼ .867,
respectively) who underwent anterior cervical surgery. Conversely, Lee et al16 identified smoking, female gender, and the
number of fusion segments as independent risk factors for reoperation in patients undergoing ACDF. Similarly, in the study
by Bishop et al,22 smokers were found to have an increased
delayed union rate at 12 months based on radiological measurements than nonsmokers (60% for smokers vs 21% for nonsmokers). In addition, Hilibrand et al2 also found that smokers had
significantly lower fusion rates compared with nonsmokers
(smokers: 62%; nonsmokers: 81%; P < .02).
Several limitations for this current study exist, including its
retrospective nature, which can lead to potential observer and/
or reporting bias. Additionally, some data points were not
available for analysis, such as the duration of smoking cessation for patients in the former smoker cohort as well as the pack
years for current and former smokers. An additional limitation
is the fact that patients who actively use vaporizers only were
not included in the study. Self-reporting also introduces recall
bias or response bias because nonsmokers may actually be
current or former smokers. Additionally, the study was not
designed to evaluate pseudarthrosis, so although all patients
were required to have more than a year of clinical follow-up,
not all patients had appropriate imaging to determine fusion
status after surgery. Had CT imaging been obtained for each
patient, the present study would have been able to draw more
significant conclusions regarding the association between
smoking status and nonunion after ACDF.

Conclusion
In the current study, current and former smoking was associated with more severe symptoms at baseline for PCS-12, VAS
Neck pain, and VAS Arm pain scores in patients undergoing
ACDF. However, in spite of baseline differences, all groups
showed similar rates of improvement, and smoking status was
not found to be an independent predictor of patient outcomes.
These findings suggest that smoking status alone does not
influence patient-reported outcomes after ACDF.
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